# Nexentis Technologies Inc.: filings

NXTS · Nasdaq · CIK 1789192 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nxts.md) · [Financials](/companies/nxts/financials.md) · [Filings](/companies/nxts/filings.md) · [Insiders](/companies/nxts/insiders.md)

## Reports and events: 147 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 98, 4 40, 3 25, 10-Q 20, UPLOAD 14, CORRESP 10, PRE 14A 10, EFFECT 9, DEF 14A 8, SC 13G 8, SC 13G/A 8, 10-K 7, SCHEDULE 13G 7, S-1 6, S-1/A 6, SCHEDULE 13G/A 5, 424B3 4, 424B5 4, 10-12G/A 3, 8-K/A 2, S-3 2, 10-12G 1, 424B4 1, 8-A12B 1, CERT 1, DEF 14C 1, DEFA14A 1, DEFR14A 1, DEL AM 1, DRS 1, NT 10-Q 1, POS AM 1, PRE 14C 1, PREM14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:05 ET | [8-K](/filings/0001493152-26-047578.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors | 0001493152-26-047578 |
| 2026-10-06 | 13:30 ET | [8-K](/filings/0001493152-26-045885.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-045885 |
| 2026-09-03 | 20:05 ET | [8-K](/filings/0001493152-26-041358.md) | 3.01 Delisting notice | 0001493152-26-041358 |
| 2026-08-13 | 20:06 ET | [10-Q](/filings/0001493152-26-037757.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037757 |
| 2026-08-06 | 20:06 ET | [8-K](/filings/0001493152-26-036335.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-036335 |
| 2026-07-13 | 20:05 ET | [S-1](/filings/0001493152-26-033026.md) | Registration statement | 0001493152-26-033026 |
| 2026-06-22 | 20:49 ET | [8-K](/filings/0001493152-26-029611.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-029611 |
| 2026-06-12 | 20:15 ET | [8-K](/filings/0001493152-26-028439.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-028439 |
| 2026-05-27 | 20:05 ET | [8-K](/filings/0001493152-26-025397.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-025397 |
| 2026-05-14 | 20:21 ET | [10-Q](/filings/0001493152-26-023107.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023107 |
| 2026-04-30 | 20:15 ET | [8-K](/filings/0001493152-26-020509.md) | 5.07 Shareholder vote results | 0001493152-26-020509 |
| 2026-04-06 | 12:39 ET | [8-K](/filings/0001493152-26-015246.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-015246 |
| 2026-03-31 | 20:16 ET | [10-K](/filings/0001493152-26-014183.md) | Annual report, period 2025-12-31 | 0001493152-26-014183 |
| 2026-03-17 | 20:05 ET | [8-K](/filings/0001493152-26-010533.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-010533 |
| 2026-03-12 | 15:26 ET | [DEF 14A](/filings/0001493152-26-009810.md) | Proxy statement, period 2026-03-12 | 0001493152-26-009810 |
| 2026-02-26 | 21:17 ET | [8-K](/filings/0001493152-26-008175.md) | 3.02 Unregistered sale of equity | 0001493152-26-008175 |
| 2026-02-25 | 14:30 ET | [8-K](/filings/0001493152-26-007988.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure | 0001493152-26-007988 |
| 2026-01-13 | 21:05 ET | [8-K](/filings/0001493152-26-002031.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-002031 |
| 2026-01-12 | 14:15 ET | [8-K](/filings/0001493152-26-001247.md) | 3.02 Unregistered sale of equity | 0001493152-26-001247 |
| 2025-12-16 | 21:05 ET | [8-K](/filings/0001493152-25-027962.md) | 3.02 Unregistered sale of equity; 5.07 Shareholder vote results | 0001493152-25-027962 |
| 2025-11-13 | 21:32 ET | [10-Q](/filings/0001493152-25-022355.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022355 |
| 2025-11-12 | 21:06 ET | [8-K/A](/filings/0001493152-25-021907.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-021907 |
| 2025-11-03 | 21:05 ET | [DEF 14A](/filings/0001493152-25-020585.md) | Proxy statement, period 2025-11-03 | 0001493152-25-020585 |
| 2025-10-23 | 20:01 ET | [8-K](/filings/0001493152-25-019064.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019064 |
| 2025-10-08 | 13:05 ET | [8-K](/filings/0001493152-25-017377.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017377 |
| 2025-09-25 | 20:30 ET | [8-K](/filings/0001493152-25-014952.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-014952 |
| 2025-09-18 | 13:39 ET | [8-K](/filings/0001493152-25-013998.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013998 |
| 2025-09-09 | 20:15 ET | [8-K](/filings/0001493152-25-012904.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-012904 |
| 2025-08-19 | 20:42 ET | [S-1/A](/filings/0001493152-25-012164.md) | Registration statement, amended | 0001493152-25-012164 |
| 2025-08-18 | 20:05 ET | [8-K](/filings/0001493152-25-012130.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-012130 |
| 2025-08-14 | 20:21 ET | [10-Q](/filings/0001493152-25-011990.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011990 |
| 2025-08-14 | 22:07 ET | [8-K](/filings/0001493152-25-011919.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-011919 |
| 2025-08-06 | 20:06 ET | [S-1](/filings/0001641172-25-022425.md) | Registration statement | 0001641172-25-022425 |
| 2025-08-05 | 20:01 ET | [DEF 14A](/filings/0001641172-25-022235.md) | Proxy statement, period 2025-08-05 | 0001641172-25-022235 |
| 2025-07-28 | 10:04 ET | [8-K](/filings/0001493152-25-011426.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-011426 |
| 2025-07-24 | 20:05 ET | [8-K](/filings/0001493152-25-011380.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-011380 |
| 2025-05-22 | 20:05 ET | [8-K](/filings/0001641172-25-012067.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-012067 |
| 2025-05-15 | 20:05 ET | [10-Q](/filings/0001641172-25-010883.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010883 |
| 2025-05-13 | 21:02 ET | [8-K](/filings/0001641172-25-009993.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-009993 |
| 2025-05-12 | 20:10 ET | [8-K](/filings/0001641172-25-009678.md) | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors | 0001641172-25-009678 |
| 2025-04-10 | 20:05 ET | [8-K](/filings/0001641172-25-003600.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-003600 |
| 2025-03-31 | 13:19 ET | [10-K](/filings/0001641172-25-001513.md) | Annual report, period 2024-12-31 | 0001641172-25-001513 |
| 2025-03-31 | 10:15 ET | [8-K](/filings/0001641172-25-001431.md) | 3.01 Delisting notice | 0001641172-25-001431 |
| 2025-03-20 | 13:00 ET | [8-K](/filings/0001493152-25-010993.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-010993 |
| 2025-03-17 | 13:00 ET | [8-K](/filings/0001493152-25-010502.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-010502 |
| 2025-02-28 | 14:15 ET | [8-K](/filings/0001493152-25-008629.md) | 1.01 Entry into a material agreement | 0001493152-25-008629 |
| 2025-02-26 | 14:15 ET | [8-K](/filings/0001493152-25-008294.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008294 |
| 2025-02-14 | 14:43 ET | [S-1/A](/filings/0001493152-25-006622.md) | Registration statement, amended | 0001493152-25-006622 |
| 2025-02-07 | 21:24 ET | [S-1/A](/filings/0001493152-25-005400.md) | Registration statement, amended | 0001493152-25-005400 |
| 2025-02-07 | 15:31 ET | [8-K](/filings/0001493152-25-005327.md) | 8.01 Other events | 0001493152-25-005327 |

Page 1 of 3. [Older](/companies/nxts/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.